Profile picture

Professor Zlatko Fras

University Medical Centre of Ljubljana, Ljubljana (Slovenia)
Membership: FESC Member
Follow
Biography
He was awarded his academical (MD (1990), MSc (1994), PhD (2008)) degrees at Faculty of Medicine, University of Ljubljana (FM-UL), and is licensed Specialist of both (1) Internal Medicine and (2) Cardiology & Vascular Medicine. His clinical activities encompass different aspects in CV medicine, while his scientific work is focused on atherosclerosis and disorders of lipid metabolism, epidemiology and preventive cardiology. From 2008 he holds position of Medical Director, Division of Medicine, at the UMC Ljubljana, and Professor of Internal Medicine (Circulation), at the FM-UL (Chair of Internal Medicine). He is state appointed Chairman of the Slovene National Programme on CVD Prevention, and President of the Slovenian Society of Cardiology. In 2001 elected as Fellow of the ESC, and in 2013 as Fellow of the ACC. He served as President of the UEMS (2006-11). He is (co-)author of 680 scientific units - full list available online at www.cobiss.si - national scientific bibliography system.
Logo ESC

Contributor content

Achieving lipid goals in the real world (1)
Session
Achieving lipid goals in the real world (1)
24 April 2026
Advancing precision in lipid risk assessment and management
Session
Advancing precision in lipid risk assessment and management
23 April 2026
Novel biomarkers for cardiovascular risk assessment
Session
Novel biomarkers for cardiovascular risk assessment
1 September 2025
Cardiovascular risk assessment
Session
Cardiovascular risk assessment
1 September 2025
Coronary revascularisation – state of the art for chronic coronary syndromes
Session
Coronary revascularisation – state of the art for chronic coronary syndromes
29 August 2022
Cardiovascular risk assessment - Scores 1
Session
Cardiovascular risk assessment - Scores 1
27 August 2022
SGLT2 inhibitors in clinical practice
Session
SGLT2 inhibitors in clinical practice
27 August 2022
Current issues in lipid-lowering therapy
Session
Current issues in lipid-lowering therapy
27 August 2022
Lipids 1
Session
Lipids 1
26 August 2022
Cardiac biomarkers for atherosclerotic cardiovascular disease risk prediction
Session
Cardiac biomarkers for atherosclerotic cardiovascular disease risk prediction
30 August 2021

ESC 365 is supported by